
Please try another search
Hualan Biological Vaccine Inc. engages in the research, development, production, and sale of vaccines in China. It offers influenza virus split vaccines, quadrivalent influenza virus split vaccines, influenza A (H1N1) virus split vaccines, ACYW135 group meningococcal polysaccharide vaccines, recombinant hepatitis B vaccines, group A and C meningococcal polysaccharide vaccines, freeze-dried human rabies vaccine, and tetanus vaccines, as well as genetic engineering of biological products. The company also sells self-produced products. The company was founded in 2005 and is based in Xinxiang, China.
Name | Age | Since | Title |
---|---|---|---|
Yuancheng Lou | 40 | 2020 | Supervisory Board Chairman |
Bei Fan | 52 | 2020 | Non-Independent Director |
Wenqi An | 45 | 2020 | Non-Independent Director |
Wenjue An | 35 | 2022 | GM & Director |
Yang Dong Sheng | 60 | 2020 | Independent Director |
Xiaowei Ma | 56 | 2020 | Non-Independent Director |
Kang An | 75 | 2020 | Non-Independent Chairman |
Dexin Li | 71 | 2020 | Independent Director |
Chaoyuan Ma | 41 | 2020 | Non-Employee Supervisor |
Ruowen Pan | 57 | 2020 | Executive VP & Director |
Xinlei Hu | 36 | 2023 | Supervisor |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review